A guide for active learning in synergistic drug discovery
Abstract Synergistic drug combination screening is a promising strategy in drug discovery, but it involves navigating a costly and complex search space. While AI, particularly deep learning, has advanced synergy predictions, its effectiveness is limited by the low occurrence of synergistic drug pair...
Saved in:
Main Authors: | Shuhui Wang, Alexandre Allauzen, Philippe Nghe, Vaitea Opuu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-85600-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linking machine learning and biophysical structural features in drug discovery
by: Armin Ahmadi, et al.
Published: (2025-01-01) -
Integrating pharmacogenomics and cheminformatics with diverse disease phenotypes for cell type-guided drug discovery
by: Arda Halu, et al.
Published: (2025-01-01) -
Drug discovery: a multifactorial ecosystem
by: Fernando Albericio
Published: (2023-01-01) -
Guided Discovery with Socratic Questioning
by: M. Hakan Türkçapar, et al.
Published: (2015-04-01) -
New strategies to enhance the efficiency and precision of drug discovery
by: Qi An, et al.
Published: (2025-02-01)